House Bill 4122 would add two related protections in Massachusetts law concerning abortion and emergency contraception. First, it would amend Chapter 111 to make it an unfair or deceptive act under Chapter 93A for a person to advertise that they provide abortions, emergency contraceptives, or referrals for either, if they know or reasonably should know that they do not actually provide those services. The bill defines “emergency contraceptive” as an FDA-approved contraceptive method for use after sexual intercourse, whether over-the-counter or prescription.
Second, the bill would amend Chapter 112 to prohibit licensed health care professionals from providing, prescribing, administering, or attempting “medication abortion reversal,” defined as using a drug with the intent to interfere with, reverse, or halt a medication abortion. A violation would subject the licensee to disciplinary action by the relevant licensing board. Overall, the bill is aimed at regulating misleading reproductive-health advertising and restricting a practice the bill characterizes as medically improper.
Impact
The bill would expand the scope of Massachusetts consumer protection law by expressly treating false advertising about abortion services and emergency contraception as an unfair or deceptive trade practice under Chapter 93A. It would also create a new professional conduct restriction in Chapter 112 for licensed practitioners, giving licensing boards authority to discipline providers who engage in medication abortion reversal. The practical effect would be to affect clinics, crisis pregnancy centers, advertisers, and licensed medical professionals involved in reproductive health services.
Sentiment
No committee transcripts or recorded votes were provided, so there is no direct evidence of legislative debate or formal support/opposition in the available record. Based on the bill text alone, the measure appears to be framed as a consumer-protection and professional-discipline bill, with supporters likely emphasizing truthful advertising and patient protection. The absence of recorded votes or discussion means the overall sentiment cannot be measured from the available materials.
Contention
The main points of contention are likely to center on abortion policy, free-speech and advertising regulation, and the medical legitimacy of medication abortion reversal. Supporters would likely argue that the bill prevents misleading public claims and protects patients seeking reproductive-health care. Opponents may argue that the advertising provision could burden pregnancy-resource organizations or other entities that discuss abortion-related services, and that the medication abortion reversal ban intrudes on provider judgment or conflicts with claims about treatment options. No specific individuals or groups are identified in the provided record, so these are inferred policy fault lines rather than documented positions.